Search for: All records

Developments in nanomolecular engineering in the last 20 years have led to the development of technology that uses ultrasonic irradiation in initiating the polymerization process for wider industrial and commercial applications. In this experimental study, ultrasound-assisted reversible addition chain-transfer (Sono-RAFT) polymerization was used to differentiate the effects of the bulk and continuous flow polymerization methods on three parameters─monomer conversion, polymer molar mass, and dispersity─using 2-hydroxyethyl acrylate, N-acryloyl morpholine, and N-dimethylacetamide as monomer substrates. Experimental results indicate that continuous flow polymerization demonstrated higher monomer conversion than polymerizations performed in batch under identical experimental conditions. Furthermore, the increased surface-to-volume ratio inherent to continuous flow reactors enabled Sono-RAFT at a higher monomer concentration than analogous batch reactions due to the higher cavitational intensity accessible in tubular microreactors. The key to continuous flow Sono-RAFT was the observation that stainless-steel microreactors result in increased cavitational intensity and decreased oxygen contamination compared to PFA tubing. We envision that these findings will further advance the field of mechanochemistry in polymer science and provide an approach to make sonochemically regulated polymerization more practical and sustainable. 

The synchronization dynamics for the circadian gene expression in the suprachiasmatic nucleus is investigated using a transcriptional circadian clock gene oscillator model. With global coupling in constant dark (DD) conditions, the model exhibits a one-cluster phase synchronized state, in dim light (dim LL), bistability between one- and two-cluster states and in bright LL, a two-cluster state. The two-cluster phase synchronized state, where some oscillator pairs synchronize in-phase, and some anti-phase, can explain the splitting of the circadian clock, i.e., generation of two bouts of daily activities with certain species, e.g., with hamsters. The one- and two-cluster states can be reached by transferring the animal from DD or bright LL to dim LL, i.e., the circadian synchrony has a memory effect. The stability of the one- and two-cluster states was interpreted analytically by extracting phase models from the ordinary differential equation models. In a modular network with two strongly coupled oscillator populations with weak intragroup coupling, with appropriate initial conditions, one group is synchronized to the one-cluster state and the other group to the two-cluster state, resulting in a weak-chimera state. Computational modeling suggests that the daily rhythms in sleep–wake depend on light intensity acting on bilateral networks of suprachiasmatic nucleus (SCN) oscillators. Addition of a network heterogeneity (coupling between the left and right SCN) allowed the system to exhibit chimera states. The simulations can guide experiments in the circadian rhythm research to explore the effect of light intensity on the complexities of circadian desynchronization. 

NKX3.1’s downregulation is strongly associated with prostate cancer (PCa) initiation, progression, and CRPC development. Nevertheless, a clear disagreement exists between NKX3.1 protein and mRNA levels in PCa tissues, indicating that its regulation at a post-translational level plays a vital role. This study identified a strong negative relationship between NKX3.1 and LIMK2, which is critical in CRPC pathogenesis. We identified that NKX3.1 degradation by direct phosphorylation by LIMK2 is crucial for promoting oncogenicity in CRPC cells and in vivo. LIMK2 also downregulates NKX3.1 mRNA levels. In return, NKX3.1 promotes LIMK2’s ubiquitylation. Thus, the negative crosstalk between LIMK2-NKX3.1 regulates AR, ARv7, and AKT signaling, promoting aggressive phenotypes. We also provide a new link between NKX3.1 and PTEN, both of which are downregulated by LIMK2. PTEN loss is strongly linked with NKX3.1 downregulation. As NKX3.1 is a prostate-specific tumor suppressor, preserving its levels by LIMK2 inhibition provides a tremendous opportunity for developing targeted therapy in CRPC. Further, as NKX3.1 downregulates AR transcription and inhibits AKT signaling, restoring its levels by inhibiting LIMK2 is expected to be especially beneficial by co-targeting two driver pathways in tandem, a highly desirable requisite for developing effective PCa therapeutics.